Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs.

[1]  C. Lang,et al.  Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine. , 2015, Cardiovascular therapeutics.

[2]  Deepak L. Bhatt,et al.  Heart Rate at Hospital Discharge in Patients With Heart Failure Is Associated With Mortality and Rehospitalization , 2015, Journal of the American Heart Association.

[3]  J. Cleland,et al.  Prescribing patterns to optimize heart rate: analysis of 1,000 consecutive outpatient appointments to a single heart failure clinic over a 6-month period. , 2015, JACC. Heart failure.

[4]  P. Austin,et al.  Association of Heart Rate at Hospital Discharge With Mortality and Hospitalizations in Patients With Heart Failure , 2014, Circulation. Heart failure.

[5]  J. Duchenne,et al.  Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. , 2013, The American journal of cardiology.

[6]  C. Yancy,et al.  The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial. , 2013, JACC. Heart failure.

[7]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[8]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[9]  P. Ponikowski,et al.  Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long‐Term Registry , 2013, European journal of heart failure.

[10]  Deepak L. Bhatt,et al.  Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation. , 2012, American heart journal.

[11]  J. Cleland,et al.  Heart rate achieved or beta‐blocker dose in patients with chronic heart failure: which is the better target? , 2012, European journal of heart failure.

[12]  S. Solomon,et al.  Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program. , 2012, Journal of the American College of Cardiology.

[13]  G. Fonarow,et al.  Medication dosing in outpatients with heart failure after implementation of a practice-based performance improvement intervention: findings from IMPROVE HF. , 2012, Congestive heart failure.

[14]  H. Katus,et al.  Optimization of pharmacotherapy in chronic heart failure: is heart rate adequately addressed? , 2012, Clinical Research in Cardiology.

[15]  J. McMurray,et al.  The Heart failure and Optimal Outcomes from Pharmacy Study (HOOPS): rationale, design, and baseline characteristics , 2011, European journal of heart failure.

[16]  Ankur Gupta,et al.  Ivabradine and outcomes in chronic heart failure , 2010, The Lancet.

[17]  K. Swedberg,et al.  Improved pharmacological therapy of chronic heart failure in primary care: a randomized Study of NT‐proBNP Guided Management of Heart Failure – SIGNAL‐HF (Swedish Intervention study – Guidelines and NT‐proBNP AnaLysis in Heart Failure) , 2010, European journal of heart failure.

[18]  P. Ponikowski,et al.  EURObservational Research Programme: The Heart Failure Pilot Survey (ESC‐HF Pilot) , 2010, European journal of heart failure.

[19]  Michael Böhm,et al.  Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study , 2010, The Lancet.

[20]  C. O'connor,et al.  Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). , 2008, American heart journal.

[21]  P. Decouflé,et al.  National sources of vital status information: extent of coverage and possible selectivity in reporting. , 1990, American journal of epidemiology.